HOLYPHARM
Home
|
Products
|
About Us
|
News
|
Contact Us
English
中文
English
日本語
한국어
Español
Français
NEWS
Study on the kidney benefits of semaglutide
2025-07-22
In recent years, GLP-1 receptor agonists have gained significant attention in diabetes and weight management. Among them, semaglutide stands out not only for its excellent glycemic and weight control
NEWS
Tirzepatide: A Dual Agonist Redefining Metabolic Disease Treatment
2025-07-22
Tirzepatide is a novel peptide drug developed by Eli Lilly, approved by the FDA for the treatment of type 2 diabetes, and shows strong potential in weight management. Unlike traditional GLP-1 receptor
NEWS
Overview of Citric Acid Functions
2025-07-22
Citric acid is a naturally occurring organic acid found widely in citrus fruits. It was first isolated from lemon juice in 1784 by Swedish chemist Carl Wilhelm Scheele. With the molecular formula C₆H₈
NEWS
Hangzhou HolyPharm Biotech Co.,ltd
Science and Innovation for a Healthier Life
CONTACT US
Address: T2-805, European and American Financial City, Cangqian Street, Yuhang District, Hangzhou, China.
Email: info@holypharm.com
Tel: +86-0571-8875 2329
FOLLOW US